Cannabis Conference Heads to Berlin Amid EU Expansion
ICBC set for Berlin as Europe leads cannabis policy shift
The International Cannabis Business Conference returns to Berlin April 13-15, 2026, as Germany continues to lead European cannabis policy reform.
The ICBC has tracked Germany's evolving cannabis landscape since the country legalized medical marijuana in 2017. Now, with recreational legalization under active discussion in the Bundestag, Berlin has become the de facto capital of Europe's emerging cannabis industry.
"Europe's policy changes have been remarkable, and Germany is leading the charge," said ICBC founder Alex Rogers. "The Berlin conference will be essential for anyone interested in the future of cannabis in Europe."
Germany's Policy Evolution
Germany legalized medical cannabis in 2017, becoming one of the first major European economies to do so. The program has grown steadily, with over 300,000 registered patients as of 2024.
The current government coalition has made adult-use legalization a priority, though implementation has faced regulatory and EU law challenges. The April conference will feature policymakers discussing the path forward.
Conference Focus
The ICBC agenda will address:
- Regulatory frameworks across European markets
- Cross-border commerce and EU law considerations
- Investment opportunities in emerging markets
- Lessons learned from mature markets like Canada and U.S. states
Key speakers include members of the German parliament, European cannabis business leaders, and legal experts navigating the complex EU regulatory environment.
European Market Outlook
Several European countries are watching Germany's approach closely. Portugal, the Netherlands, and Luxembourg have all advanced cannabis reform discussions in recent years.
The European cannabis market remains fragmented, with each country maintaining its own regulatory framework. But industry observers expect Germany's eventual adult-use legalization to create pressure for EU-wide policy harmonization.
For U.S. and Canadian cannabis companies, Europe represents a significant growth opportunity—but one that requires understanding of distinct regulatory systems and consumer preferences.
This article is based on original reporting by Ganjapreneur.
Original Source
This article is based on reporting from Ganjapreneur.
Read the original articleOriginal title: "International Cannabis Business Conference Returns To Berlin April 13-15, 2026"
Related Topics
Related Stories
Industry NewsIndustry Veteran Calls for Unified Cannabis and Hemp Regulations
Cannabis entrepreneur Jason Leisey argues that maintaining separate regulatory standards for marijuana and hemp products creates dangerous loopholes that threaten consumer trust and industry credibility.
Industry NewsHemp Entrepreneur Fires Back at Industry Critics, Blames Consolidation
Hemp business owner John Grady argues regulatory pressure on hemp products isn't about consumer safety—it's about large cannabis operators using regulation to eliminate competition from smaller hemp companies.
LegislationRescheduling Won't Fix Cannabis Industry Without Insurance Access
Cannabis industry experts argue Trump's rescheduling order won't stabilize the market without insurance reimbursement access, which matters more than tax relief for long-term viability.
More from Alex Morgan
View all articles
Massachusetts Halts Cultivation Licenses as Prices Drop to $14/Eighth
Spain's Cannabis Concentrate Market Shifts From BHO to Rosin
Trump Publicly Pressures DOJ on Marijuana Rescheduling Delays
